mTORC1 activation induced proximal tubular damage via the pentose phosphate pathway in lupus nephritis

More recent studies suggested that metabolic disorders could contribute to the pathogenesis of systemic lupus erythematosus (SLE) and lupus nephritis (LN). The present work aimed at identifying metabolic reprogramming in the kidney of lupus nephritis via proteomics and investigating the potential re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Free radical biology & medicine 2022-08, Vol.189, p.91-101
Hauptverfasser: Mao, Zhaomin, Tan, Ying, Tao, Juan, Li, Linlin, Yu, Feng, Zhao, Minghui
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 101
container_issue
container_start_page 91
container_title Free radical biology & medicine
container_volume 189
creator Mao, Zhaomin
Tan, Ying
Tao, Juan
Li, Linlin
Yu, Feng
Zhao, Minghui
description More recent studies suggested that metabolic disorders could contribute to the pathogenesis of systemic lupus erythematosus (SLE) and lupus nephritis (LN). The present work aimed at identifying metabolic reprogramming in the kidney of lupus nephritis via proteomics and investigating the potential regulatory mechanism. The proteomic studies on the renal biopsies revealed that the pentose phosphate pathway (PPP) was significantly enriched in the kidneys of LN patients compared with normal controls (NCs). Immunohistochemical stanning of glucose-6-phosphate dehydrogenase (G6PD), the key rate-limiting enzyme of PPP, verify the results of proteomics. We found that G6PD was highly expressed in the kidneys of LN patients and correlated with several clinicopathological indices. The univariate Cox regression analysis (HR, 95%CI, 1.877 (1.059–3.328), P = 0.031) and Kaplan-Meier (KM) analysis (P = 0.028) suggested that high G6PD expression in the tubulointerstitial area was a risk factor for worse prognosis. Moreover, the Gene set enrichment analysis (GSEA) demonstrated that the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway ranked first in the kidneys of LN patients with high G6PD expression and G6PD was co-localized with mTORC1 activation in the tubule. Immunoglobulin G (IgG) isolated from LN patients significantly activated the mTORC1 pathway and increased G6PD expression, G6PD activity, NADPH production, NADPH oxidase 2 (NOX2) expression, reactive oxygen species (ROS) production, and cell apoptosis in tubule cells in vitro. The above phenotypes were partially rescued after the addition of rapamycin or knock-down of G6PD. Overall, our study suggested that renal G6PD expression was associated with the overall enhanced disease activity and worse renal prognosis. mTORC1 activation might be involved in IgG-LN-induced tubular damage via PPP. [Display omitted] •In lupus nephritis, renal G6PD was correlated with the disease activity.•Tubulointerstitial G6PD expression could predict the renal outcome in lupus nephritis.•mTORC1 mediated tubular damage through pentose phosphate pathway activation.
doi_str_mv 10.1016/j.freeradbiomed.2022.07.010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2693776737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0891584922004920</els_id><sourcerecordid>2693776737</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-1b354a1f68d2a910577c25f69c16ddcc93a44f4ab4c4a6d644e21767e27313393</originalsourceid><addsrcrecordid>eNqNkEtr3DAUhUVJoZNp_4Ogm2zsSpYs2WRVhjwKgUBJ1-KOdF1r8KuSPMn8-2qYbLrr6tzFOYd7PkK-clZyxtW3Q9kFxABu7-cRXVmxqiqZLhlnH8iGN1oUsm7VFdmwpuVF3cj2E7mO8cAYk7VoNqQbX55_7jgFm_wRkp8n6ie3WnR0CfObH2Ggad2vAwTqYITfSI8eaOqRLjilOWbt57j0kPIFqX-FU26gw7qskU649MEnHz-Tjx0MEb-865b8ur972T0WT88PP3bfnworFEsF34taAu9U4ypoOau1tlXdqdZy5Zy1rQApOwl7aSUop6TEimulsdKCC9GKLbm59Obn_6wYkxl9tDgMMOG8RlOpVugcEDpbby9WG-YYA3ZmCXluOBnOzJmuOZh_6JozXcO0yXRz-u6Sxrzm6DGYaD1OmZsPaJNxs_-vnr8epYw8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2693776737</pqid></control><display><type>article</type><title>mTORC1 activation induced proximal tubular damage via the pentose phosphate pathway in lupus nephritis</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Mao, Zhaomin ; Tan, Ying ; Tao, Juan ; Li, Linlin ; Yu, Feng ; Zhao, Minghui</creator><creatorcontrib>Mao, Zhaomin ; Tan, Ying ; Tao, Juan ; Li, Linlin ; Yu, Feng ; Zhao, Minghui</creatorcontrib><description>More recent studies suggested that metabolic disorders could contribute to the pathogenesis of systemic lupus erythematosus (SLE) and lupus nephritis (LN). The present work aimed at identifying metabolic reprogramming in the kidney of lupus nephritis via proteomics and investigating the potential regulatory mechanism. The proteomic studies on the renal biopsies revealed that the pentose phosphate pathway (PPP) was significantly enriched in the kidneys of LN patients compared with normal controls (NCs). Immunohistochemical stanning of glucose-6-phosphate dehydrogenase (G6PD), the key rate-limiting enzyme of PPP, verify the results of proteomics. We found that G6PD was highly expressed in the kidneys of LN patients and correlated with several clinicopathological indices. The univariate Cox regression analysis (HR, 95%CI, 1.877 (1.059–3.328), P = 0.031) and Kaplan-Meier (KM) analysis (P = 0.028) suggested that high G6PD expression in the tubulointerstitial area was a risk factor for worse prognosis. Moreover, the Gene set enrichment analysis (GSEA) demonstrated that the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway ranked first in the kidneys of LN patients with high G6PD expression and G6PD was co-localized with mTORC1 activation in the tubule. Immunoglobulin G (IgG) isolated from LN patients significantly activated the mTORC1 pathway and increased G6PD expression, G6PD activity, NADPH production, NADPH oxidase 2 (NOX2) expression, reactive oxygen species (ROS) production, and cell apoptosis in tubule cells in vitro. The above phenotypes were partially rescued after the addition of rapamycin or knock-down of G6PD. Overall, our study suggested that renal G6PD expression was associated with the overall enhanced disease activity and worse renal prognosis. mTORC1 activation might be involved in IgG-LN-induced tubular damage via PPP. [Display omitted] •In lupus nephritis, renal G6PD was correlated with the disease activity.•Tubulointerstitial G6PD expression could predict the renal outcome in lupus nephritis.•mTORC1 mediated tubular damage through pentose phosphate pathway activation.</description><identifier>ISSN: 0891-5849</identifier><identifier>EISSN: 1873-4596</identifier><identifier>DOI: 10.1016/j.freeradbiomed.2022.07.010</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>G6PD ; Lupus nephritis ; mTORC1 ; Pentose phosphate pathway</subject><ispartof>Free radical biology &amp; medicine, 2022-08, Vol.189, p.91-101</ispartof><rights>2022 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-1b354a1f68d2a910577c25f69c16ddcc93a44f4ab4c4a6d644e21767e27313393</citedby><cites>FETCH-LOGICAL-c360t-1b354a1f68d2a910577c25f69c16ddcc93a44f4ab4c4a6d644e21767e27313393</cites><orcidid>0000-0002-9029-7252</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.freeradbiomed.2022.07.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Mao, Zhaomin</creatorcontrib><creatorcontrib>Tan, Ying</creatorcontrib><creatorcontrib>Tao, Juan</creatorcontrib><creatorcontrib>Li, Linlin</creatorcontrib><creatorcontrib>Yu, Feng</creatorcontrib><creatorcontrib>Zhao, Minghui</creatorcontrib><title>mTORC1 activation induced proximal tubular damage via the pentose phosphate pathway in lupus nephritis</title><title>Free radical biology &amp; medicine</title><description>More recent studies suggested that metabolic disorders could contribute to the pathogenesis of systemic lupus erythematosus (SLE) and lupus nephritis (LN). The present work aimed at identifying metabolic reprogramming in the kidney of lupus nephritis via proteomics and investigating the potential regulatory mechanism. The proteomic studies on the renal biopsies revealed that the pentose phosphate pathway (PPP) was significantly enriched in the kidneys of LN patients compared with normal controls (NCs). Immunohistochemical stanning of glucose-6-phosphate dehydrogenase (G6PD), the key rate-limiting enzyme of PPP, verify the results of proteomics. We found that G6PD was highly expressed in the kidneys of LN patients and correlated with several clinicopathological indices. The univariate Cox regression analysis (HR, 95%CI, 1.877 (1.059–3.328), P = 0.031) and Kaplan-Meier (KM) analysis (P = 0.028) suggested that high G6PD expression in the tubulointerstitial area was a risk factor for worse prognosis. Moreover, the Gene set enrichment analysis (GSEA) demonstrated that the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway ranked first in the kidneys of LN patients with high G6PD expression and G6PD was co-localized with mTORC1 activation in the tubule. Immunoglobulin G (IgG) isolated from LN patients significantly activated the mTORC1 pathway and increased G6PD expression, G6PD activity, NADPH production, NADPH oxidase 2 (NOX2) expression, reactive oxygen species (ROS) production, and cell apoptosis in tubule cells in vitro. The above phenotypes were partially rescued after the addition of rapamycin or knock-down of G6PD. Overall, our study suggested that renal G6PD expression was associated with the overall enhanced disease activity and worse renal prognosis. mTORC1 activation might be involved in IgG-LN-induced tubular damage via PPP. [Display omitted] •In lupus nephritis, renal G6PD was correlated with the disease activity.•Tubulointerstitial G6PD expression could predict the renal outcome in lupus nephritis.•mTORC1 mediated tubular damage through pentose phosphate pathway activation.</description><subject>G6PD</subject><subject>Lupus nephritis</subject><subject>mTORC1</subject><subject>Pentose phosphate pathway</subject><issn>0891-5849</issn><issn>1873-4596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqNkEtr3DAUhUVJoZNp_4Ogm2zsSpYs2WRVhjwKgUBJ1-KOdF1r8KuSPMn8-2qYbLrr6tzFOYd7PkK-clZyxtW3Q9kFxABu7-cRXVmxqiqZLhlnH8iGN1oUsm7VFdmwpuVF3cj2E7mO8cAYk7VoNqQbX55_7jgFm_wRkp8n6ie3WnR0CfObH2Ggad2vAwTqYITfSI8eaOqRLjilOWbt57j0kPIFqX-FU26gw7qskU649MEnHz-Tjx0MEb-865b8ur972T0WT88PP3bfnworFEsF34taAu9U4ypoOau1tlXdqdZy5Zy1rQApOwl7aSUop6TEimulsdKCC9GKLbm59Obn_6wYkxl9tDgMMOG8RlOpVugcEDpbby9WG-YYA3ZmCXluOBnOzJmuOZh_6JozXcO0yXRz-u6Sxrzm6DGYaD1OmZsPaJNxs_-vnr8epYw8</recordid><startdate>20220820</startdate><enddate>20220820</enddate><creator>Mao, Zhaomin</creator><creator>Tan, Ying</creator><creator>Tao, Juan</creator><creator>Li, Linlin</creator><creator>Yu, Feng</creator><creator>Zhao, Minghui</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9029-7252</orcidid></search><sort><creationdate>20220820</creationdate><title>mTORC1 activation induced proximal tubular damage via the pentose phosphate pathway in lupus nephritis</title><author>Mao, Zhaomin ; Tan, Ying ; Tao, Juan ; Li, Linlin ; Yu, Feng ; Zhao, Minghui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-1b354a1f68d2a910577c25f69c16ddcc93a44f4ab4c4a6d644e21767e27313393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>G6PD</topic><topic>Lupus nephritis</topic><topic>mTORC1</topic><topic>Pentose phosphate pathway</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mao, Zhaomin</creatorcontrib><creatorcontrib>Tan, Ying</creatorcontrib><creatorcontrib>Tao, Juan</creatorcontrib><creatorcontrib>Li, Linlin</creatorcontrib><creatorcontrib>Yu, Feng</creatorcontrib><creatorcontrib>Zhao, Minghui</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Free radical biology &amp; medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mao, Zhaomin</au><au>Tan, Ying</au><au>Tao, Juan</au><au>Li, Linlin</au><au>Yu, Feng</au><au>Zhao, Minghui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>mTORC1 activation induced proximal tubular damage via the pentose phosphate pathway in lupus nephritis</atitle><jtitle>Free radical biology &amp; medicine</jtitle><date>2022-08-20</date><risdate>2022</risdate><volume>189</volume><spage>91</spage><epage>101</epage><pages>91-101</pages><issn>0891-5849</issn><eissn>1873-4596</eissn><abstract>More recent studies suggested that metabolic disorders could contribute to the pathogenesis of systemic lupus erythematosus (SLE) and lupus nephritis (LN). The present work aimed at identifying metabolic reprogramming in the kidney of lupus nephritis via proteomics and investigating the potential regulatory mechanism. The proteomic studies on the renal biopsies revealed that the pentose phosphate pathway (PPP) was significantly enriched in the kidneys of LN patients compared with normal controls (NCs). Immunohistochemical stanning of glucose-6-phosphate dehydrogenase (G6PD), the key rate-limiting enzyme of PPP, verify the results of proteomics. We found that G6PD was highly expressed in the kidneys of LN patients and correlated with several clinicopathological indices. The univariate Cox regression analysis (HR, 95%CI, 1.877 (1.059–3.328), P = 0.031) and Kaplan-Meier (KM) analysis (P = 0.028) suggested that high G6PD expression in the tubulointerstitial area was a risk factor for worse prognosis. Moreover, the Gene set enrichment analysis (GSEA) demonstrated that the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway ranked first in the kidneys of LN patients with high G6PD expression and G6PD was co-localized with mTORC1 activation in the tubule. Immunoglobulin G (IgG) isolated from LN patients significantly activated the mTORC1 pathway and increased G6PD expression, G6PD activity, NADPH production, NADPH oxidase 2 (NOX2) expression, reactive oxygen species (ROS) production, and cell apoptosis in tubule cells in vitro. The above phenotypes were partially rescued after the addition of rapamycin or knock-down of G6PD. Overall, our study suggested that renal G6PD expression was associated with the overall enhanced disease activity and worse renal prognosis. mTORC1 activation might be involved in IgG-LN-induced tubular damage via PPP. [Display omitted] •In lupus nephritis, renal G6PD was correlated with the disease activity.•Tubulointerstitial G6PD expression could predict the renal outcome in lupus nephritis.•mTORC1 mediated tubular damage through pentose phosphate pathway activation.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.freeradbiomed.2022.07.010</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-9029-7252</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0891-5849
ispartof Free radical biology & medicine, 2022-08, Vol.189, p.91-101
issn 0891-5849
1873-4596
language eng
recordid cdi_proquest_miscellaneous_2693776737
source Elsevier ScienceDirect Journals Complete
subjects G6PD
Lupus nephritis
mTORC1
Pentose phosphate pathway
title mTORC1 activation induced proximal tubular damage via the pentose phosphate pathway in lupus nephritis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T08%3A11%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=mTORC1%20activation%20induced%20proximal%20tubular%20damage%20via%20the%20pentose%20phosphate%20pathway%20in%20lupus%20nephritis&rft.jtitle=Free%20radical%20biology%20&%20medicine&rft.au=Mao,%20Zhaomin&rft.date=2022-08-20&rft.volume=189&rft.spage=91&rft.epage=101&rft.pages=91-101&rft.issn=0891-5849&rft.eissn=1873-4596&rft_id=info:doi/10.1016/j.freeradbiomed.2022.07.010&rft_dat=%3Cproquest_cross%3E2693776737%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2693776737&rft_id=info:pmid/&rft_els_id=S0891584922004920&rfr_iscdi=true